Franklin Resources
AMPH icon

Franklin Resources’s Amphastar Pharmaceuticals AMPH Stock Holding History

Franklin Resources’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$504K Sell
24,986
-114,319
-82% -$2.31M ﹤0.01% 2572
2026
Q1 		$2.73M Buy
139,305
+113,260
+435% +$2.77M ﹤0.01% 1800
2025
Q4 		$697K Buy
26,045
+16,520
+173% +$426K ﹤0.01% 2253
2025
Q3 		$254K Buy
+9,525
New +$246K ﹤0.01% 2739
2025
Q2 		– Sell
-20,260
Closed -$587K – 3030
2025
Q1 		$587K Sell
20,260
-7,145
-26% -$228K ﹤0.01% 2199
2024
Q4 		$1.02M Sell
27,405
-1,060
-4% -$48.5K ﹤0.01% 1991
2024
Q3 		$1.4M Sell
28,465
-175
-0.6% -$7.68K ﹤0.01% 1845
2024
Q2 		$1.15M Buy
28,640
+2,970
+12% +$123K ﹤0.01% 1879
2024
Q1 		$1.13M Sell
25,670
-894
-3% -$46.2K ﹤0.01% 1909
2023
Q4 		$1.64M Sell
26,564
-186
-0.7% -$9.77K ﹤0.01% 1458
2023
Q3 		$1.23M Sell
26,750
-836
-3% -$45.6K ﹤0.01% 1540
2023
Q2 		$1.59M Buy
27,586
+18,053
+189% +$800K ﹤0.01% 1488
2023
Q1 		$357K Sell
9,533
-59
-0.6% -$1.93K ﹤0.01% 1805
2022
Q4 		$269K Buy
9,592
+8
+0.1% +$232 ﹤0.01% 1898
2022
Q3 		$269K Sell
9,584
-2,741
-22% -$89.5K ﹤0.01% 1893
2022
Q2 		$429K Sell
12,325
-4,522
-27% -$161K ﹤0.01% 1747
2022
Q1 		$605K Sell
16,847
-10,026
-37% -$284K ﹤0.01% 1765
2021
Q4 		$626K Buy
26,873
+384
+1% +$7.85K ﹤0.01% 1825
2021
Q3 		$504K Buy
26,489
+15,994
+152% +$313K ﹤0.01% 1877
2021
Q2 		$212K Buy
10,495
+129
+1% +$2.43K ﹤0.01% 1836
2021
Q1 		$190K Buy
+10,366
New +$193K ﹤0.01% 1817

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources's AMPH Position: Q2 2026 in Review

Franklin Resources reduced its Amphastar Pharmaceuticals (AMPH) stake by 82% in Q2 2026, selling an estimated $2.31M and leaving 24,986 shares worth $504K. The position accounts for ﹤0.01% of the portfolio, ranked #2572.

Franklin Resources first reported a position in AMPH in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.73M in Q1 2026. 210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Franklin Resources held 24,986 shares of Amphastar Pharmaceuticals worth $504K as of Q2 2026.
  • Franklin Resources sold 114,319 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $2.31M.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2572 holding.
  • Franklin Resources first reported a position in Amphastar Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • Franklin Resources's Amphastar Pharmaceuticals position peaked at $2.73M in Q1 2026.
  • 210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.